Under active development. Data is being added and corrected on an hourly basis.

← Back to Peptides
KPV structure

KPV

Healing & Recovery
Phase 1 Research
30%
Low Risk
1/5

Dosing Protocol

Typical Dose 400 mcg
Range 200 - 500 mcg
Maintenance 400 mcg daily

Pharmacokinetics

Half-Life 1.5 hrs
Onset 15 min
Peak 1.0 hrs
Duration 4.0 hrs
Bioavailability 85%
Primary Route Subcutaneous

Administration

Routes Subcutaneous, Oral, Topical
Injection Sites Abdomen, Thigh, Deltoid
Needle Gauge 29-31G
Syringe Type Insulin
Timing Morning, Evening

Reconstitution

Diluent Bacteriostatic Water
Volume 3 mL
Concentration 3333 mcg/mL
Stability 30 days refrigerated
Vial Sizes 5, 10 mg

Special Instructions

Oral form effective for gut inflammation. No pigmentary effects unlike full alpha-MSH.